Novel antimicrobials or new treatment strategies are urgently needed to treat Pseudomonas
aeruginosa (P. aeruginosa) related infections and especially to address the problem of …

The World Health Organization has recently published a list of 12 drug-resistant bacteria that
posed a significant threat to human health, and Pseudomonas aeruginosa (P. aeruginosa) …

The emergence of multidrug-resistant (MDR) Pseudomonas aeruginosa, coupled with
shrinking antibiotic pipelines, has increased the demand for new antimicrobials with novel …

Background Antimicrobial resistance is a growing threat to public health. Pseudomonas
aeruginosa is a relevant pathogen causing human and animal infections, frequently …

The rise in antimicrobial resistant bacteria is limiting the number of effective treatments for
bacterial infections. Escherichia coli and Pseudomonas aeruginosa are two of the …

Pseudomonas aeruginosa infections represent a serious threat to worldwide health. Proline-
rich antimicrobial peptides (PR-AMPs), a particular group of peptide antibiotics, have …

Rapidly growing antimicrobial resistance (AMR) against antibiotics has propelled the
development of synthetic antimicrobial peptides (AMPs) as potential antimicrobial agents …

Antibiotic resistance is a growing public health concern, though the constant development of
new antibiotics. The combination of high-throughput screening and drug repurposing is an …

Here, we found that simple substitution of amino acids in the middle position of the
hydrophobic face of an amphipathic peptide RI16 with tryptophan (T9W) considerably …

Hp1404, identified from the venom of the scorpion Heterometrus petersii, displays
antimicrobial activity with cytotoxicity. Several synthetic peptides were designed based on …